Articles related to FDA

In light of the voluntary recall of Neptune’s Fix due to its dangerous ingredient, tianeptine, healthcare professionals should be vigilant in advising patients against the use of unregulated supplements and emphasize the importance of FDA-approved treatments.

With more than 27,000 doses administered, CAR T-cell therapies represent a breakthrough in treating hematologic malignancies, though emerging reports of secondary T-cell cancers post-treatment highlight the importance of long-term patient monitoring and reporting.

With FDA-approved features in wearable devices for heart health monitoring and the advent of home test kits for conditions like anemia, clinicians now have innovative tools at their disposal to enhance patient care and autonomy.

HyQvia, now FDA-approved for CIDP, shows a significant reduction in relapse rates, presenting an effective subcutaneous alternative to IVIG infusions.

Explore groundbreaking therapies in the pipeline: Onivyde for pancreatic cancer, showing marked survival benefits, and roluperidone, offering new hope in managing schizophrenia’s negative symptoms.

In a major stride for cervical cancer treatment, the FDA-approved pembrolizumab in combination with CRT demonstrates significant improvement in progression-free survival for FIGO 2014 stage III-IVA patients, marking a pivotal change in therapeutic approaches.